&lt;i&gt;CRPPA&lt;/i&gt; exon 6-9 deletion as a founder mutation in Chinese patients with dystroglycanopathy. This evidence concerns the gene CRPPA and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.